Mike Polark
Stock Analyst at Baird
(3.52)
# 801
Out of 4,829 analysts
71
Total ratings
48.89%
Success rate
5.64%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $151.25 | +56.03% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $137.70 | +8.93% | 8 | May 2, 2025 | |
| PODD Insulet | Downgrades: Peer Perform | n/a | $310.67 | - | 3 | Apr 29, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $22.68 | +27.89% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $73.68 | -18.57% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $245.04 | -26.54% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $95.21 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $380.92 | +6.32% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $44.06 | +24.83% | 8 | Aug 28, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $536.51 | -6.25% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $133.24 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $125.11 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $84.67 | +42.91% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $22.98 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $13.13 | +90.40% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $156.57 | +5.38% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $102.86 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $83.48 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $12.95 | +0.42% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $6.21 | +238.16% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $226.43 | +10.41% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.77 | +2,329.38% | 1 | Sep 2, 2020 |
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $151.25
Upside: +56.03%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $137.70
Upside: +8.93%
Insulet
Apr 29, 2025
Downgrades: Peer Perform
Price Target: n/a
Current: $310.67
Upside: -
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $22.68
Upside: +27.89%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $73.68
Upside: -18.57%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $245.04
Upside: -26.54%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $95.21
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $380.92
Upside: +6.32%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $44.06
Upside: +24.83%
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $536.51
Upside: -6.25%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $133.24
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $125.11
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $84.67
Upside: +42.91%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $22.98
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $13.13
Upside: +90.40%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $156.57
Upside: +5.38%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $102.86
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $83.48
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $12.95
Upside: +0.42%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $6.21
Upside: +238.16%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $226.43
Upside: +10.41%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.77
Upside: +2,329.38%